Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation.
Saved in:
| Title: | Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation. |
|---|---|
| Authors: | Mou E; Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Falchi L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sundaram V; Quantitative Science Unit, Stanford University School of Medicine, Palo Alto, CA, USA., Abramson JS; Massachusetts General Hospital, Yawkey Center, Boston, MA, USA., Balassanian R; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Beygi S; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Fitzpatrick MJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Frank AK; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Gupta S; Department of Pathology, University of Virginia, Charlottesville, VA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Lin O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Reed JR; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA., Long SR; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA., Ly A; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Menke JR; Department of Pathology, Stanford University, Stanford, CA, USA., Reed DR; Section of Hematology and Oncology, Wake Forest Baptist Medical Comprehensive Cancer Center.; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Ruiz-Cordero R; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Volaric AK; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA., Xie Y; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wang L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wen KW; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Zadeh SL; Department of Pathology, University of Virginia, Charlottesville, VA, USA., Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA., Cheung MC; Division of Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Gratzinger D; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Pathology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. |
| Corporate Authors: | Cyto-Heme Institutional Collaborative (CHIC) consortium |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2864-2872. Date of Electronic Publication: 2021 Jun 26. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34176413 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mou+E%22">Mou E</searchLink>; Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Falchi+L%22">Falchi L</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sundaram+V%22">Sundaram V</searchLink>; Quantitative Science Unit, Stanford University School of Medicine, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Abramson+JS%22">Abramson JS</searchLink>; Massachusetts General Hospital, Yawkey Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Balassanian+R%22">Balassanian R</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Beygi+S%22">Beygi S</searchLink>; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fitzpatrick+MJ%22">Fitzpatrick MJ</searchLink>; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Frank+AK%22">Frank AK</searchLink>; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Department of Pathology, University of Virginia, Charlottesville, VA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+O%22">Lin O</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Reed+JR%22">Reed JR</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Long+SR%22">Long SR</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ly+A%22">Ly A</searchLink>; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Menke+JR%22">Menke JR</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Reed+DR%22">Reed DR</searchLink>; Section of Hematology and Oncology, Wake Forest Baptist Medical Comprehensive Cancer Center.; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA.<br /><searchLink fieldCode="AU" term="%22Ruiz-Cordero+R%22">Ruiz-Cordero R</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Volaric+AK%22">Volaric AK</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA.<br /><searchLink fieldCode="AU" term="%22Xie+Y%22">Xie Y</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wen+KW%22">Wen KW</searchLink>; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zadeh+SL%22">Zadeh SL</searchLink>; Department of Pathology, University of Virginia, Charlottesville, VA, USA.<br /><searchLink fieldCode="AU" term="%22Natkunam+Y%22">Natkunam Y</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cheung+MC%22">Cheung MC</searchLink>; Division of Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Gratzinger+D%22">Gratzinger D</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Pathology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Cyto-Heme+Institutional+Collaborative+%28CHIC%29+consortium%22">Cyto-Heme Institutional Collaborative (CHIC) consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2864-2872. <i>Date of Electronic Publication: </i>2021 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34176413 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2021.1941936 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2864 Titles: – TitleFull: Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mou E – PersonEntity: Name: NameFull: Falchi L – PersonEntity: Name: NameFull: Sundaram V – PersonEntity: Name: NameFull: Abramson JS – PersonEntity: Name: NameFull: Balassanian R – PersonEntity: Name: NameFull: Beygi S – PersonEntity: Name: NameFull: Fitzpatrick MJ – PersonEntity: Name: NameFull: Frank AK – PersonEntity: Name: NameFull: Gupta S – PersonEntity: Name: NameFull: Lin O – PersonEntity: Name: NameFull: Reed JR – PersonEntity: Name: NameFull: Long SR – PersonEntity: Name: NameFull: Ly A – PersonEntity: Name: NameFull: Menke JR – PersonEntity: Name: NameFull: Reed DR – PersonEntity: Name: NameFull: Ruiz-Cordero R – PersonEntity: Name: NameFull: Volaric AK – PersonEntity: Name: NameFull: Xie Y – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Wen KW – PersonEntity: Name: NameFull: Zadeh SL – PersonEntity: Name: NameFull: Natkunam Y – PersonEntity: Name: NameFull: Cheung MC – PersonEntity: Name: NameFull: Gratzinger D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2021 Dec Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 62 – Type: issue Value: 12 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |